AGIO | AGIOS PHARMACEUTICALS INC

CUSIP: 00847X104

0 Funds Holding
0 Total Shares
$0 Total Value
$28.66
Price
$1.7B
Market Cap
P/E Ratio
-4.4
Forward P/E
$-7.01
EPS (TTM)
Dividend Yield
$953M
Cash
$57M
Total Debt
58M
Shares Out
$22.24
$46.00
52-Week Range

Institutional Ownership of AGIOS PHARMACEUTICALS INC

Fund / Manager Click to search
Shares Value % of Portfolio Cost Basis Est. Return
No funds currently hold this stock.

Trading Activity for AGIOS PHARMACEUTICALS INC

Fund / Manager Click to search
Action Change Shares After Value Price
No activity found for this stock.

Insider Trading for AGIOS PHARMACEUTICALS INC

6 Months Insider Sentiment
100%
Buy $0 Sell $902K
0 Buys
7 Sells
-902K Net
0 Grants
Largest
$338K Goff
$169K Goff
$79K Jones
Date
Insider Click to search
Role Click to search
Type Shares Price Value
Jan 05, 2026 Tsveta Milanova Chief Commercial Officer EXERCISE 8.5K
Jan 05, 2026 Tsveta Milanova Chief Commercial Officer SELL 2.9K $27.02 $78K
Dec 30, 2025 Brian Goff Chief Executive Officer SELL 6.2K $27.09 $169K
Dec 30, 2025 Brian Goff Chief Executive Officer SELL 12.5K $27.09 $338K
Dec 30, 2025 Cecilia Jones Chief Financial Officer EXERCISE 6.0K
Dec 30, 2025 Cecilia Jones Chief Financial Officer SELL 2.9K $27.09 $79K
Dec 30, 2025 James William Burns Chief Legal Officer EXERCISE 6.0K
Dec 30, 2025 Brian Goff Chief Executive Officer EXERCISE 12.8K
Dec 30, 2025 Sarah Gheuens Chief Medical Officer EXERCISE 6.0K
Dec 30, 2025 Sarah Gheuens Chief Medical Officer SELL 2.9K $27.09 $79K
Dec 30, 2025 Tsveta Milanova Chief Commercial Officer EXERCISE 6.0K
Dec 30, 2025 Tsveta Milanova Chief Commercial Officer SELL 2.9K $27.09 $79K
Dec 30, 2025 James William Burns Chief Legal Officer SELL 2.9K $27.09 $79K
Dec 30, 2025 Brian Goff Chief Executive Officer EXERCISE 25.5K